RET-Positive Metastatic NSCLC


WCLC 2022 on the Phase II DOLPHIN Study: Durvalumab + Concurrent RT in Unresectable Locally Advanced NSCLC

70 views
August 29, 2022
0 Comments
Login to view comments. Click here to Login